A new study, conducted by the Atrial Fibrillation NETwork (AFNET), offered smartphone and arrhythmia screening to older adults without atrial fibrillation.
New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
Dr Gill Lowe in the Institute of Cardiovascular Sciences, University of Birmingham has been appointed National Haematology Specialty Lead
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
Dr Melanie Madhani has been internationally recognised by the Japan Society for the Promotion of Science (JSPS) for her outstanding research.
New research uncovers the role of mast cells in Covid-19, and mast cell stabilizers could be efficient and safe in tackling the blockage of blood vessels.
Professor Claudio Mauro has been awarded a British Heart Foundation Senior Research Fellowship towards research in immunometabolism in atherosclerosis.
New research with families in Chile looking at a rare genetic defect suggests that new, more powerful drugs to prevent dangerous clotting would be safe.
Healthcare data research should follow a framework to ensure transparency at every stage, according to experts across research, regulation and patient advocacy.